Clinical Trial Update: Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing neoadjuvant immunochemotherapy to neoadjuvant chemotherapy for resectable esophageal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Esophageal Cancer, Surgery | Phase 3 | Status: RECRUITING